Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refractory Lymphoma

Clinical trial NCT00061672 · COMPLETED

Trial details

NCT number: NCT00061672
Sponsor: Abbott
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, Non-Hodgkin Hodgkin's Lymphoma

Start date: 2003-04-01
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.